slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,471
Current window 35,401-35,430
Pages 3,683
Rows per page 30
Component
35,401-35,430 of 110,471
272
The slide uses a Q&A format to provide credibility to the claims made by former KLA executives.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 2 hits
276
The slide uses direct quotes from industry experts to build a bearish case against Lasertec.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 2 hits
31
The slide uses strong, emotive language ('flop', 'scathing', 'mind-numbingly difficult') to frame the problem.Berkeley Lights (BLI) · Scorpion Capital
Research note Short seller Beat · Exposure of ContradictionsLoop · Cost Of Inaction2 hits
32
The slide presents a series of critical testimonials from industry experts/employees, framing the company as a failing investment.Berkeley Lights (BLI) · Scorpion Capital
Research note Short seller Beat · Exposure of ContradictionsLoop · Cost Of Inaction2 hits
33
The slide uses strong, emotive language ('debacle', 'farce', 'tricked', 'loathes') to frame the product as a failure.Berkeley Lights (BLI) · Scorpion Capital
Research note Short seller Beat · Exposure of ContradictionsLoop · Cost Of Inaction2 hits
34
The slide uses strong, negative language to frame the subject as a failed product/vendor.Berkeley Lights (BLI) · Scorpion Capital
Research note Short seller Beat · Exposure of ContradictionsLoop · Cost Of Inaction2 hits
35
The slide presents qualitative expert testimony to build a case against the target company's product viability.Berkeley Lights (BLI) · Scorpion Capital
Research note Short seller Beat · Exposure of ContradictionsLoop · Cost Of Inaction2 hits
36
The slide uses a 'villain critique' style to undermine the value proposition of the BLI machine through expert testimony.Berkeley Lights (BLI) · Scorpion Capital
Research note Short seller Beat · Exposure of Contradictions2 hits
129
The slide uses expert testimony to undermine the company's value proposition.Berkeley Lights (BLI) · Scorpion Capital
Research note Short seller Beat · Testimonials from Customers and Former Employees2 hits
02
The slide uses a comparative historical analogy (Seldane) to frame the current safety concerns as a 'tragedy in the making'.Harmony Biosciences (HRMY) · Kir Kahlon
Regulatory filing Short seller Beat · ComplicationLoop · Pattern Hunter2 hits
97
The slide uses a Q&A format to present qualitative evidence of corporate malfeasance.Ginkgo Bioworks (DNA) · Scorpion Capital
Activist deck Short seller Beat · Expose Contradiction2 hits
175
The slide uses direct quotes to draw a parallel between Ginkgo and Zymergen, framing Ginkgo's business model as lacking substance ('secret sauce').Ginkgo Bioworks (DNA) · Scorpion Capital
Activist deck Short seller Beat · Expose Contradiction2 hits
15
The slide uses a narrative structure to present evidence of corporate misconduct and operational failure.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Monster2 hits
42
The slide uses highlighted text to emphasize key admissions regarding management's role in stopping the study.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle2 hits
83
The slide uses a Q&A format to present expert testimony as evidence of product failure.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
84
The slide uses a Q&A transcript format to build a case against the efficacy of pitolisant based on historical failures at Abbott.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
91
The slide uses a Q&A transcript format to validate the thesis that the H3 receptor class is fundamentally flawed.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
100
The slide uses highlighted text to emphasize key quotes from expert interviews.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
111
The slide uses a 'villain critique' style to highlight a lack of transparency in clinical trial reporting.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
154
The slide uses a 'villain critique' style to frame the FDA's approval as flawed and the drug's safety as compromised.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
165
The slide uses a 'preempt_rebuttal' strategy by highlighting a specific safety concern (eosinophilic abnormality) that the authors claim was ignored in official FDA review documents.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
27
Uses LinkedIn bio excerpts and press release data to frame a narrative of corporate instability and potential fraud.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller Beat · The Struggle to Overcome Technical Challenges2 hits
49
Uses legal terminology ('mens rea') to frame corporate disclosure changes as evidence of intent to deceive.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits
52
The slide uses direct quotes from a QC Ware executive to corroborate claims of misleading marketing regarding qubit counts.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits
65
Uses direct quotes from interviews to undermine the credibility of company marketing materials.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits
106
The slide uses direct quotes from a 'leading expert' to undermine the credibility of IonQ's co-founder Chris Monroe.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits
133
The slide uses a 'before-after' or 'claim-reality' framing to set up a series of investigative findings.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits
138
The slide uses a Q&A format to expose the lack of commercial traction for IonQ's hardware through a partner's testimony.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits
142
The slide uses red boxes to highlight specific partners and claims, likely to contrast them with other findings in the activist deck.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller Beat · The Conclusion that IonQ's Claims are Exaggerated2 hits
150
The slide uses a narrative structure to cast doubt on the legitimacy of the company's announcements.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller Beat · The Conclusion that IonQ's Claims are Exaggerated2 hits